-
Current management strategies for ovarian cancer.
Mayo Clin Proc. 2007 Jun;82(6):751-70
PMID: 17550756
-
Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.
Proteomics. 2005 Sep;5(14):3790-7
PMID: 16121334
-
False discovery rates and related statistical concepts in mass spectrometry-based proteomics.
J Proteome Res. 2008 Jan;7(1):47-50
PMID: 18067251
-
Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma.
Proteomics. 2006 Nov;6(21):5880-90
PMID: 17022098
-
Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments.
J Proteome Res. 2006 Jan;5(1):112-21
PMID: 16396501
-
Mining the plasma proteome for cancer biomarkers.
Nature. 2008 Apr 3;452(7187):571-9
PMID: 18385731
-
Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.
Cancer Res. 1983 Nov;43(11):5379-89
PMID: 6604576
-
Glucocorticoids stabilize HER-2/neu messenger RNA in human epithelial ovarian carcinoma cells.
Gynecol Oncol. 1994 Apr;53(1):70-7
PMID: 7909787
-
Plasma proteomic pattern as biomarkers for ovarian cancer.
Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:139-46
PMID: 16515582
-
Up-regulation of tumor susceptibility gene 101 conveys poor prognosis through suppression of p21 expression in ovarian cancer.
Clin Cancer Res. 2007 Jul 1;13(13):3848-54
PMID: 17606716
-
Calsyntenin-1, a proteolytically processed postsynaptic membrane protein with a cytoplasmic calcium-binding domain.
Mol Cell Neurosci. 2001 Jan;17(1):151-66
PMID: 11161476
-
Comparative proteome analysis of human epithelial ovarian cancer.
Proteome Sci. 2007 Sep 24;5:16
PMID: 17892554
-
The PeptideAtlas project.
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D655-8
PMID: 16381952
-
Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes.
J Proteome Res. 2007 Sep;6(9):3558-65
PMID: 17696519
-
Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.
Anal Chem. 2002 Oct 15;74(20):5383-92
PMID: 12403597
-
Locating proteins in the cell using TargetP, SignalP and related tools.
Nat Protoc. 2007;2(4):953-71
PMID: 17446895
-
Soluble cadherins as cancer biomarkers.
Clin Exp Metastasis. 2007;24(8):685-97
PMID: 17952616
-
A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC).
Nat Protoc. 2006;1(6):2650-60
PMID: 17406521
-
Quantitative proteomics analysis of the secretory pathway.
Cell. 2006 Dec 15;127(6):1265-81
PMID: 17174899
-
A gene atlas of the mouse and human protein-encoding transcriptomes.
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6062-7
PMID: 15075390
-
A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers.
J Proteome Res. 2008 Jan;7(1):339-51
PMID: 18076136
-
Innovative proteomic approaches for cancer biomarker discovery.
Biotechniques. 2007 Sep;43(3):279, 281-3, 285
PMID: 17907570
-
Distribution of 15 human kallikreins in tissues and biological fluids.
Clin Chem. 2007 Aug;53(8):1423-32
PMID: 17573418
-
Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function.
J Biol Chem. 2003 Feb 28;278(9):7607-16
PMID: 12493773
-
Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours.
Anticancer Res. 2007 Jul-Aug;27(4C):2753-8
PMID: 17695443
-
Large-scale proteomics analysis of human ovarian cancer for biomarkers.
J Proteome Res. 2007 Apr;6(4):1440-50
PMID: 17315909
-
The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells.
Mol Cancer Res. 2007 Dec;5(12):1246-53
PMID: 18171982
-
Advantages of combined transmembrane topology and signal peptide prediction--the Phobius web server.
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W429-32
PMID: 17483518
-
A model for random sampling and estimation of relative protein abundance in shotgun proteomics.
Anal Chem. 2004 Jul 15;76(14):4193-201
PMID: 15253663
-
Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.
Cancer Res. 2007 Mar 1;67(5):2030-9
PMID: 17332331
-
A statistical model for identifying proteins by tandem mass spectrometry.
Anal Chem. 2003 Sep 1;75(17):4646-58
PMID: 14632076
-
Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations.
Lancet Oncol. 2007 Sep;8(9):813-21
PMID: 17765190
-
Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.
Cancer Res. 2002 Aug 15;62(16):4722-9
PMID: 12183431
-
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma.
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11531-6
PMID: 10500211
-
Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.
Nature. 2007 May 24;447(7143):482-6
PMID: 17495932
-
Comparative proteomics of ovarian epithelial tumors.
J Proteome Res. 2006 May;5(5):1082-90
PMID: 16674097
-
Cancer statistics, 2007.
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
PMID: 17237035
-
Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
Cancer Res. 1991 Oct 1;51(19):5181-7
PMID: 1717140
-
Ovarian cancer metastasis: integrating insights from disparate model organisms.
Nat Rev Cancer. 2005 May;5(5):355-66
PMID: 15864277